Artiva Biotherapeutics Cash Flow Statement (2023-2026) | ARTV

Cash Flow Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -11.31M11.23M-11.60M-13.84M-28.05M-33.80M-23.21M-36.84M-36.75M-23.36M-21.18M-35.20M
Depreciation and Depletion (Quarter) 0.50M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M0.60M
Share-based Compensation (Quarter) 1.37M1.39M1.41M1.48M1.91M2.18M0.44M1.55M7.40M19.70M
Cash from Operations (Quarter) -10.75M-10.68M-15.09M-13.69M-11.61M-14.65M-19.84M-22.98M-19.20M-14.78M-20.95M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.28M0.37M0.27M0.66M1.04M0.72M0.51M0.36M0.29M0.20M
Depreciation & Amortization (CF) (Quarter) 0.50M0.56M0.59M0.59M0.60M0.63M0.61M0.63M0.64M0.66M0.67M0.67M
Change in Working Capital
Change in Receivables (Quarter) -0.08M-1.10M-0.21M-0.25M-0.57M
Change in Account Payables (Quarter) 1.59M-1.92M0.85M-0.95M0.70M-0.08M0.04M-0.21M-0.44M-0.15M1.81M
Change in Accured Expenses (Quarter) -0.36M0.14M-3.04M0.27M3.10M-0.99M-0.93M-0.55M1.12M2.37M-4.00M
Other Working Capital Changes (Quarter) -23.73M-1.31M
Investing Activities
Capital Expenditures (Quarter) 2.69M-2.76M0.01M0.47M-0.58M0.15M0.88M-0.60M0.14M-0.23M0.24M
Change in Acquisitions & Divestments (Quarter) 12.00M12.80M16.00M14.00M12.40M13.95M29.00M28.25M29.62M24.00M22.00M
Cash from Investing Activities (Quarter) -0.49M-2.67M9.78M1.35M-130.63M-0.97M9.97M21.12M16.28M16.04M15.32M
Financing Activities
Other financing activities (Quarter) 0.01M0.02M0.14M
Change in Capital Stock
Shares Issued (Quarter) 1.06M1.11M1.17M1.36M0.60M0.61M
Misc.
Cash from Financing Activities (Quarter) 23.43M0.96M163.87M-0.03M0.24M-0.07M-0.04M-0.12M-0.11M
Change in Cash (Quarter) 12.19M-12.38M-5.30M-13.95M21.63M-15.65M-9.63M-1.93M-2.96M1.19M-5.75M
Free Cash Flow (Quarter) -13.43M-7.91M-15.10M-14.15M-11.04M-14.80M-20.72M-22.38M-19.34M-14.54M-21.19M
Net Cash Flow (Quarter) 12.19M-12.38M-5.30M-12.34M21.63M-15.65M-9.63M-1.93M-2.96M1.14M-5.75M